1. Home
  2. ETJ vs IVVD Comparison

ETJ vs IVVD Comparison

Compare ETJ & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

ETJ

Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

HOLD

Current Price

$8.41

Market Cap

543.8M

Sector

Finance

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$1.37

Market Cap

437.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETJ
IVVD
Founded
N/A
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
543.8M
437.1M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
ETJ
IVVD
Price
$8.41
$1.37
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$8.75
AVG Volume (30 Days)
164.0K
3.0M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.02
EPS
N/A
N/A
Revenue
N/A
$53,426,000.00
Revenue This Year
N/A
$61.57
Revenue Next Year
N/A
$41.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
110.47
52 Week Low
$7.88
$0.49
52 Week High
$9.12
$3.07

Technical Indicators

Market Signals
Indicator
ETJ
IVVD
Relative Strength Index (RSI) 52.86 39.49
Support Level N/A $1.17
Resistance Level $9.04 $1.41
Average True Range (ATR) 0.10 0.11
MACD 0.01 -0.02
Stochastic Oscillator 42.82 7.05

Price Performance

Historical Comparison
ETJ
IVVD

About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials. Under normal market conditions, the Fund's investment program consists of majorly owning a diversified portfolio of common stocks and employing a variety of options strategies.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: